- Home
- NI vs TEVA Comparison
NI vs TEVA Comparison
Compare NI & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NI
- TEVA
- Stock Information
- Founded
- NI 1912
- TEVA 1901
- Country
- NI United States
- TEVA Israel
- Employees
- NI N/A
- TEVA N/A
- Industry
- NI Power Generation
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- NI Utilities
- TEVA Health Care
- Exchange
- NI Nasdaq
- TEVA Nasdaq
- Market Cap
- NI 16.1B
- TEVA 19.2B
- IPO Year
- NI N/A
- TEVA N/A
- Fundamental
- Price
- NI $37.69
- TEVA $17.12
- Analyst Decision
- NI Strong Buy
- TEVA Strong Buy
- Analyst Count
- NI 8
- TEVA 8
- Target Price
- NI $37.50
- TEVA $19.63
- AVG Volume (30 Days)
- NI 4.1M
- TEVA 7.6M
- Earning Date
- NI 10-30-2024
- TEVA 11-06-2024
- Dividend Yield
- NI 2.81%
- TEVA N/A
- EPS Growth
- NI 9.78
- TEVA N/A
- EPS
- NI 1.64
- TEVA N/A
- Revenue
- NI $5,289,300,000.00
- TEVA $16,772,000,000.00
- Revenue This Year
- NI $12.76
- TEVA $4.70
- Revenue Next Year
- NI $3.75
- TEVA $4.47
- P/E Ratio
- NI $22.98
- TEVA N/A
- Revenue Growth
- NI N/A
- TEVA 9.81
- 52 Week Low
- NI $24.80
- TEVA $9.35
- 52 Week High
- NI $38.07
- TEVA $19.31
- Technical
- Relative Strength Index (RSI)
- NI 71.36
- TEVA 44.64
- Support Level
- NI $35.90
- TEVA $16.15
- Resistance Level
- NI $36.40
- TEVA $17.17
- Average True Range (ATR)
- NI 0.58
- TEVA 0.49
- MACD
- NI 0.18
- TEVA -0.04
- Stochastic Oscillator
- NI 89.33
- TEVA 30.54
About NI NiSource Inc
NiSource is one of the nation's largest natural gas distribution companies with approximately 3.2 million customers in Indiana, Kentucky, Maryland, Ohio, Pennsylvania, and Virginia. NiSource's electric utility transmits and distributes electricity in northern Indiana to about 500,000 customers. The regulated electric utility also owns more than 3,000 megawatts of generation capacity, including coal, natural gas, and renewable energy.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.